The Recall Desk

Manufacturer

Otsuka Pharmaceutical Development & Commercialization, Inc.

2 recalls in our database name Otsuka Pharmaceutical Development & Commercialization, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
2
Critical
0
Severe
0
Most recent
2018-10-10

Of the 2 recalls from Otsuka Pharmaceutical Development & Commercialization, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–2 of 2

  • LowFDA (Drugs)·D-0017-2019·2018-10-10

    Otsuka Recalls Mislabeled treatNOW Abilify Physician Sample Kits

    Otsuka is recalling 17,325 treatNOW Abilify physician sample kits due to labeling errors, including misspelled product names and missing storage instructions.

    Product
    treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Di
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0018-2019·2018-10-10

    Otsuka Recalls Mislabeled Abilify and Abilify Maintena Physician Sample Kits

    Otsuka is recalling 4,738 physician sample kits of Abilify and Abilify Maintena due to labeling errors, including misspelled product names and missing storage instructions.

    Product
    treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs Abilify Tablets 10 mg (14 day supply) plus 1 Abilfy Maintena Vial Kit.Rx only. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)

company in Princeton, United States

Country
United States
Founded
2007

Official website

Source: Wikidata (Q140351345), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.